Literature DB >> 15003659

Immunization with meningococcal polysaccharide-tetanus toxoid conjugate induces polysaccharide-reactive T cells in mice.

Subramanian Muthukkumar1, Kathryn E Stein.   

Abstract

T cell clones were generated from mice immunized with a meningococcal group C (alpha2 --> 9-sialic acid) polysaccharide-tetanus toxoid (MCPS-TT) conjugate. Many clones were found to be specific for tetanus toxoid (TT), however, clones reactive with MCPS-TT and polysaccharide (PS) were isolated. Two clones were specific for MCPS and two cross-reacted with Escherichia coli K1-PS (alpha2 --> 8-sialic acid). Both TT and PS reactive clones were CD4+ and CD8-. TT and MCPS-TT-specific T cell clones were major histocompatibility complex (MHC) restricted, however, the PS-reactive clones were not. Both MHC-restricted TT clones and non-restricted PS clones, however, were dependent on contact with antigen presenting cells (APC) for maximal stimulation. The data suggest that multivalent repeating epitopes on PS antigen (Ag) can overcome the need for MHC restricted interactions, but not the requirement for cell-cell contact.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003659     DOI: 10.1016/j.vaccine.2003.08.047

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

Review 1.  Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence.

Authors:  Aia Assaf-Casals; Ghassan Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

2.  Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?

Authors:  Theodore F Tsai; Ray Borrow; Hanspeter E Gnehm; Bernard Vaudaux; Ulrich Heininger; Daniel Desgrandchamps; Christoph Aebi; Paul Balmer; Ronald D Pedersen; Bernard Fritzell; Claire-Anne Siegrist
Journal:  Clin Vaccine Immunol       Date:  2006-08

3.  Differential idiotype utilization for the in vivo type 14 capsular polysaccharide-specific Ig responses to intact Streptococcus pneumoniae versus a pneumococcal conjugate vaccine.

Authors:  Jesus Colino; Leah Duke; Swadhinya Arjunaraja; Quanyi Chen; Leyu Liu; Alexander H Lucas; Clifford M Snapper
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

4.  Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.

Authors:  Raphael Simon; Sharon M Tennant; Jin Y Wang; Patrick J Schmidlein; Andrew Lees; Robert K Ernst; Marcela F Pasetti; James E Galen; Myron M Levine
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

Review 5.  Carbohydrates as T-cell antigens with implications in health and disease.

Authors:  Lina Sun; Dustin R Middleton; Paeton L Wantuch; Ahmet Ozdilek; Fikri Y Avci
Journal:  Glycobiology       Date:  2016-05-28       Impact factor: 4.313

6.  The nature of an in vivo anti-capsular polysaccharide response is markedly influenced by the composition and/or architecture of the bacterial subcapsular domain.

Authors:  Swadhinya Arjunaraja; Paola Massari; Lee M Wetzler; Andrew Lees; Jesus Colino; Clifford M Snapper
Journal:  J Immunol       Date:  2011-12-07       Impact factor: 5.422

7.  Structurally identical capsular polysaccharide expressed by intact group B streptococcus versus Streptococcus pneumoniae elicits distinct murine polysaccharide-specific IgG responses in vivo.

Authors:  Swadhinya Arjunaraja; Lawrence C Paoletti; Clifford M Snapper
Journal:  J Immunol       Date:  2012-04-20       Impact factor: 5.422

8.  Mouse dendritic cells pulsed with capsular polysaccharide induce resistance to lethal pneumococcal challenge: roles of T cells and B cells.

Authors:  Noam Cohen; Raanan Margalit; Meirav Pevsner-Fischer; Simon Yona; Steffen Jung; Lea Eisenbach; Irun R Cohen
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

9.  T Cell-Mediated Humoral Immune Responses to Type 3 Capsular Polysaccharide of Streptococcus pneumoniae.

Authors:  Dustin R Middleton; Lina Sun; Amy V Paschall; Fikri Y Avci
Journal:  J Immunol       Date:  2017-05-31       Impact factor: 5.422

Review 10.  Tumor-Associated Glycans and Immune Surveillance.

Authors:  Behjatolah Monzavi-Karbassi; Anastas Pashov; Thomas Kieber-Emmons
Journal:  Vaccines (Basel)       Date:  2013-06-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.